Clinical Trial Update: BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of BPI-361175 in advanced non-small cell lung cancer is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BPI-361175

Snippet

Sponsor: Xcovery Holdings, Inc. | Conditions: Non-small Cell Lung Carcinoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING